We found only the knockdown of BIM increased apoptotic cells following gefitinib treatment (Fig. 6), which is compatible with the IHC finding that only BIM expression has an impact on PFS in patients with EGFR-mutant NSCLC receiving EGFR-TKI treatment. This evidence concerns the gene BCL2L11 and non-small cell lung carcinoma.